Aroa Biosurgery
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · New Zealand · 201-500 Employees
View Company Info for Free
Overview
Headquarters
64 Richard Pearse Drive, Auckland, Auckl...Phone Number
+64 98693035Website
www.aroa.comRevenue
$44 MillionStock Symbol
ARXIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Aroa Biosurgery
Aroa Biosurgery, founded in 2008 and formerly known as Mesynthes, is a biotechnology research and development company specializing in medical devices and regenerative tissue products. Based in Auckland, New Zealand with operations in North America, the company develops advanced wound care and surgical solutions. Their product portfolio includes Endoform Dermal Template for chronic non-healing wounds and Reinforced Bioscaffold for ventral hernia repair and abdominal wall reconstruction. Aroa Biosurgery focuses on creating innovative medical solutions that have received FDA clearance and are distributed internationally through strategic partnerships and joint ventures.Explore more
Aroa Biosurgery Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Aroa Biosurgery your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Aroa Biosurgery
Earning: See what the market has to say on Aroa Biosurgery recently announced quarterly report
Funding: Get notified immidiatlly once Aroa Biosurgery has new funding data
Aroa Biosurgery, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Aroa Biosurgery has recently received funding, and reach out quickly before it becomes old news!
Check out if Aroa Biosurgery is spiking on competitors!
Product Launch: Get notified when Aroa Biosurgery launches new products
Click to see if Aroa Biosurgery had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Aroa Biosurgery
Find more new buyers
Company Profile Activity
Activity Insights
Aroa Biosurgery is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Aroa Biosurgery is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Aroa Biosurgery.
Aroa Biosurgery Tech Stack
A closer look at the technologies used by Aroa Biosurgery
Most Recent Scoops
Project
Aroa Biosurgery has reported that OviTex demonstrates recurrence rates of less than 3% across multiple studies for hernia procedures, compared to historical industry rates of 10% to 30%, with current sales of NZD 15 million and a total addressable market opportunity estimated at over NZD 1 billion.
Sales
Project
Aroa Biosurgery has completed a randomized controlled trial for the treatment of diabetic foot ulcers using Symphony, with the study meeting its primary endpoint, and the results are expected to be published and support Symphony's efficacy in the US outpatient skin substitute market.
Medical Research, Pharmaceuticals, Clinical Operations
Project
Aroa Biosurgery has published the largest study of lower limb salvage procedures using Myriad, involving 130 patients, demonstrating strong results, with Myriad performing particularly well in complex trauma and lower limb salvage cases, which account for approximately 75% of hospital procedures in this category.
Medical Research
Project
Aroa Biosurgery has submitted for publication a randomized controlled trial comparing Symphony against the standard of care, involving just over 140 patients, with all study endpoints met, and expects publication within 4 to 8 weeks, with the addressable market opportunity in the reset reimbursement environment estimated at over $1 billion.
Medical Research, Pharmaceuticals
Earnings
Earnings, Finance, Financial Operations
Aroa Biosurgery News & Media
Aroa Biosurgery Limited (AROAF) Shareholder/Analyst Call Transcript
Aroa Biosurgery Limited (AROAF) Shareholder/Analyst Call August 18, 2026 7:00 PM EDTCompany ParticipantsJames McLeanJames Agnew - CFO & Joint Company...Aroa Biosurgery Limited announces the recent appointments of Michael Lynskey and Mike Falcon to its US-based commercial team.
AUCKLAND, New Zealand, July 28, 2026 /PRNewswire/ -- Aroa Biosurgery Limited announces the recent appointments of Michael Lynskey and Mike Falcon to its US-based commercial team. AROA has been investing in expanding its commercial organisation to support its growth strategy and adoption...Aroa Biosurgery Limited (AROAF) Q4 2026 Earnings Call Transcript
Aroa Biosurgery Limited (AROAF) Q4 2026 Earnings Call May 25, 2026 7:00 PM EDTCompany ParticipantsBrian Ward - Founder, CEO, MD & Executive...AROA Biosurgery Completes Randomised Controlled Trial for Symphony™; Preliminary Read-Out indicates Primary Endpoint Met
AUCKLAND, New Zealand, March 29, 2026 /PRNewswire/ -- Aroa Biosurgery Limited today announced completion of its randomised controlled trial (RCT) evaluating Symphony, with a preliminary study read-out indicating the trial achieved its primary endpoint. Symphony is AROA's Cellular,...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Aroa Biosurgery
Sign Up For FreeTo access detailed company insights
Aroa Biosurgery, founded in 2008 and formerly known as Mesynthes, is a biotechnology research and development company specializing in medical devices and regenerative tissue products. Based in Auckland, New Zealand with operations in North America, the company develops advanced wound care and surgical solutions. Their product portfolio includes End... Read More
